Education
About Us
Working with TipRanks
Follow Us
Chiome Bioscience Inc. (JP:4583)
:4583
RESEARCH TOOLSreports
4583 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥75.00 - ¥304.00
Previous CloseN/A
Volume5.12M
Average Volume (3M)1.38M
Market Cap
¥9.87B
Enterprise Value¥8.53B
Total Cash (Recent Filing)¥2.06B
Total Debt (Recent Filing)¥281.50M
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Aug 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.94
Shares Outstanding68,053,800
10 Day Avg. Volume1,064,150
30 Day Avg. Volume1,377,310
Financial Highlights & Ratios
PEG Ratio-1.31
Price to Book (P/B)5.72
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Chiome Bioscience Inc. News
PremiumCompany Announcements
Chiome Bioscience Reports Q1 2025 Financial Results Amid Continued Losses
PremiumCompany Announcements
Chiome Bioscience Updates Financial Results for FY 2024
PremiumCompany Announcements
Chiome Bioscience and OmniAb Collaborate on Antibody Research
PremiumCompany Announcements
Chiome Bioscience’s Promising Results in CBA-1205 Phase I Study
PremiumCompany Announcements
Chiome Bioscience Unveils Promising Cancer Therapy Data
PremiumCompany Announcements
Chiome Bioscience Secures Licensing Deal with Asahi Kasei4583 FAQ
What was Chiome Bioscience Inc.’s price range in the past 12 months?
Chiome Bioscience Inc. lowest stock price was ¥75.00 and its highest was ¥304.00 in the past 12 months.
What is Chiome Bioscience Inc.’s market cap?
Chiome Bioscience Inc.’s market cap is ¥9.87B.
When is Chiome Bioscience Inc.’s upcoming earnings report date?
Chiome Bioscience Inc.’s upcoming earnings report date is Aug 06, 2025 which is in 13 days.
How were Chiome Bioscience Inc.’s earnings last quarter?
Currently, no data Available
Is Chiome Bioscience Inc. overvalued?
According to Wall Street analysts Chiome Bioscience Inc.’s price is currently Overvalued.
Does Chiome Bioscience Inc. pay dividends?
Chiome Bioscience Inc. does not currently pay dividends.
What is Chiome Bioscience Inc.’s EPS estimate?
Chiome Bioscience Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chiome Bioscience Inc. have?
Chiome Bioscience Inc. has 68,053,800 shares outstanding.
What happened to Chiome Bioscience Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chiome Bioscience Inc.?
Currently, no hedge funds are holding shares in JP:4583
Company Description
Chiome Bioscience Inc.
Chiome Bioscience Inc. (4583) is a biotechnology company focused on the research, development, and commercialization of therapeutic antibodies. Operating in the pharmaceutical and healthcare sectors, the company leverages its proprietary ADLib system technology to discover novel antibody candidates for various diseases, including cancer and inflammatory conditions. Chiome Bioscience aims to address unmet medical needs by developing innovative antibody-based therapies.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Chugai Pharmaceutical Co
―
Eisai Co
―
Daiichi Sankyo Company
―
AnGes
―